A Novel Temperature-Controlled Radiofrequency Catheter Ablation System Used to Treat Patients With Paroxysmal Atrial Fibrillation
OPEN JACC. Clinical electrophysiology | 1 Feb 2021
J Kautzner, JP Albenque, A Natale, W Maddox, F Cuoco, P Neuzil, H Poty, MK Getman, S Liu, Z Starek, SR Dukkipati, BJ Colley, A Al-Ahmad, DS Sidney and HT McElderry
DIAMOND-AF (DiamondTemp™ Ablation System for the Treatment of Paroxysmal Atrial Fibrillation) was a prospective, multicenter, noninferiority, randomized trial that compared the safety and effectiveness of the DTA system versus those of a force-sensing RF ablation system (control) for the treatment of patients with drug-refractory, recurrent, symptomatic paroxysmal atrial fibrillation (AF).
* Data courtesy of Altmetric.com